Dr. Isabelle Bairati, MD, Ph.D., is a full professor in the Department of Surgery of the Faculty of Medicine at Laval University, a researcher at the CHU Research Centre of Quebec-Laval University (cancer axis), and a researcher at Laval University’s Cancer Research Centre. She carries out her medical activities as a medical consultant to the board of the Capitale-Nationale’s Public Health Department.
Since her postdoctoral training at the Fred Hutchinson Cancer Research Center in Seattle, USA, Dr. Bairati’s research activities have focused on epidemiology, and the clinical epidemiology of cancers. Her research has focused on the study of modifiable risk factors, including nutrition, on the occurrence of cancers, and their prognosis. More specifically, she was the principal investigator of a chemoprevention clinical trial, testing the effectiveness of antioxidant vitamins in preventing the occurrence of second primary cancers in patients with ENT cancer. This clinical trial has shown an adverse effect of high doses of antioxidants in patients with ENT cancer (J Natl Cancer Inst., 2005). During the last 10 years, her research has focused on the study of the prognostic effect of serum, tumor and genetic markers in ENT and ovarian cancers. As a public health physician, she is also interested in the impact of the organization of oncology health services on the prognosis and satisfaction of oncology clients.
6, rue McMahon
Canada G1R 2J6
Data not available
Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.Journal Article
Int J Radiat Oncol Biol Phys, 82 (4), pp. 1454-62, 2012, ISSN: 0360-3016.
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.Journal Article
Cancer, 118 (6), pp. 1554-65, 2012, ISSN: 0008-543X.
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.Journal Article
Support Care Cancer, 20 (3), pp. 591-9, 2012, ISSN: 0941-4355.
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.Journal Article
Clin Cancer Res, 18 (1), pp. 196-206, 2012, ISSN: 1078-0432.
Factors associated with expressive and receptive language in French-speaking toddlers clinically diagnosed with language delayJournal Article
Infants Young Child, 25 (2), pp. 158-171, 2012, ISSN: 0896-3746.
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.Journal Article
Mol Oncol, 5 (5), pp. 438-53, 2011, ISSN: 1574-7891.
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.Journal Article
Int J Cancer, 128 (7), pp. 1741-6, 2011, ISSN: 0020-7136.
Factors influencing parent satisfaction with preventive health services for the early detection of speech and language delay in preschool childrenJournal Article
Open J Prev Med, 1 , pp. 135-142, 2011, ISSN: 2162-2477.
Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme.Journal Article
J Speech Lang Hear Res, 53 (3), pp. 699-709, 2010, ISSN: 1092-4388.
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.Journal Article
Cancer, 116 (9), pp. 2275-83, 2010, ISSN: 0008-543X.
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
- Centre de recherche sur le cancer, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 1996-05-01 to 2022-06-13
- Interaction between environment, diet, physical activities, and sexual habits, in the risk of prostate cancer. Validation of biomarkers to personnalize preventive interventions., Subvention, Société de recherche sur le cancer, Compétition GRePEC (SRC/FRSQ/MDEIE), from 2012-10-01 to 2021-12-31